Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (April 1994). “Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers”. Nature368 (6473): 753–6. doi:10.1038/368753a0. PMID8152487.
Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE (September 2006). “p16INK4a induces an age-dependent decline in islet regenerative potential”. Nature443 (7110): 453–7. doi:10.1038/nature05092. PMID16957737.
Rocco JW, Sidransky D (March 2001). “p16(MTS-1/CDKN2/INK4a) in cancer progression”. Exp. Cell Res.264 (1): 42–55. doi:10.1006/excr.2000.5149. PMID11237522.
Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH et al. (September 1994). “Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma”. Nat. Genet.8 (1): 27–32. doi:10.1038/ng0994-27. PMID7726912.
Bartsch D, Shevlin DW, Tung WS, Kisker O, Wells SA, Goodfellow PJ (November 1995). “Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas”. Genes Chromosomes Cancer14 (3): 189–95. doi:10.1002/gcc.2870140306. PMID8589035.
Igaki H, Sasaki H, Kishi T, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Sugimura T et al. (September 1994). “Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines”. Biochem. Biophys. Res. Commun.203 (2): 1090–5. doi:10.1006/bbrc.1994.2294. PMID8093026.
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (April 1994). “Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers”. Nature368 (6473): 753–6. doi:10.1038/368753a0. PMID8152487.
Rocco JW, Sidransky D (March 2001). “p16(MTS-1/CDKN2/INK4a) in cancer progression”. Exp. Cell Res.264 (1): 42–55. doi:10.1006/excr.2000.5149. PMID11237522.
Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH et al. (September 1994). “Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma”. Nat. Genet.8 (1): 27–32. doi:10.1038/ng0994-27. PMID7726912.
Bartsch D, Shevlin DW, Tung WS, Kisker O, Wells SA, Goodfellow PJ (November 1995). “Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas”. Genes Chromosomes Cancer14 (3): 189–95. doi:10.1002/gcc.2870140306. PMID8589035.
Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R, Hogg D (July 1995). “Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma”. Oncogene11 (2): 405–12. PMID7624155.
Igaki H, Sasaki H, Kishi T, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Sugimura T et al. (September 1994). “Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines”. Biochem. Biophys. Res. Commun.203 (2): 1090–5. doi:10.1006/bbrc.1994.2294. PMID8093026.
